Related Experiment Video
Updated: Aug 8, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
The sensitive detection and quantitation of antibody to HCV by using a microsphere-based immunoassay and flow
T M McHugh1, M K Viele, E S Chase
1Department of Laboratory Medicine, University of California at San Francisco 94143, USA. mchugh@labmed.ucsf.edu
Insights
A novel microsphere immunoassay enhanced sensitivity for detecting Hepatitis C virus (HCV) antibodies. This method improved early detection and resolved indeterminate samples, outperforming traditional enzyme immunoassays.
Area of Science:
- Immunology
- Virology
- Biotechnology
Background:
- Hepatitis C virus (HCV) infection diagnosis relies on antibody detection.
- Accurate and sensitive assays are crucial for early and reliable diagnosis.
- Current methods may face limitations in sensitivity and resolving indeterminate results.
Purpose of the Study:
- To evaluate a microsphere immunoassay for quantifying antibodies to HCV core and NS3 antigens.
- To compare the sensitivity and performance of the microsphere assay against reference methods and enzyme immunoassays.
- To assess the utility of the microsphere assay in identifying antibodies during acute HCV infection and resolving indeterminate samples.
Main Methods:
- Quantification of antibodies to HCV core and NS3 using a microsphere immunoassay combined with flow cytometry.
- Comparison of antibody detection timing in acute HCV cases against reference methods.
- Analysis of indeterminate samples using the microsphere assay versus reference methods.
- Sensitivity comparison with a 5-fold increase noted against enzyme immunoassay.
Main Results:
- Elevated antibodies to HCV core and NS3 were detected in 85 seropositive blood donors.
- The microsphere assay detected antibodies earlier than reference methods in three acute HCV cases.
- Significant resolution of indeterminate samples was observed: 25% became negative and 30% positive.
- The assay demonstrated a 5-fold increase in sensitivity compared to enzyme immunoassay.
Conclusions:
- The microsphere immunoassay offers enhanced sensitivity for quantifying specific antibodies to HCV core and NS3.
- This assay is valuable for early detection of HCV infection, particularly in acute stages.
- The microsphere assay effectively resolves a substantial proportion of indeterminate samples, improving diagnostic accuracy.
Abstract:
Antibody to HCV core and NS3 was quantified by using a microsphere immunoassay and flow cytometry. Antibody to core and NS3 was elevated in the 85 seropositive blood donors tested. The amount of either antibody varied over two logs although greater variation was seen with the antibody to NS3 than was seen with antibody to core. In three documented acute HCV cases, the microsphere assay detected antibody prior to antibody detection using the reference methods. Twenty donor samples were indeterminate by the reference methods: 45% of these were indeterminate with the microsphere assay while 25% were negative and 30% were positive. As compared to enzyme immunoassay the microsphere assay showed a 5-fold increase in sensitivity. The microsphere assay demonstrated increased sensitivity for the quantification of specific antibody to HCV core and NS3 and was useful in resolving a significant proportion of indeterminate samples.
More Related Videos
06:28Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
07:24Single-Cell Multiplexed Fluorescence Imaging to Visualize Viral Nucleic Acids and Proteins and Monitor HIV, HTLV, HBV, HCV, Zika Virus, and Influenza Infection
Published on: October 29, 2020